NATRAJPR
Natraj Proteins financials
- Market cap
- ₹14 Cr
Quarterly results
Q1 FY27: revenue up 18.3%, net profit up 274.4% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 23 | 33 | 23 | 27 | 27 +18% | 29 −14% | 19 −18% | 31 +18% |
| EBITDA | -0 | 1 | 2 | -1 | -1 −155% | 4 +462% | 2 −8% | 3 +546% |
| Net profit | -1 | 0 | 1 | -1 | -2 −63% | 3 +9533% | 1 −12% | 2 +274% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −2.9% 1Y
1Y: ₹38.7 on 9 Sept 2025 → ₹37.56. High ₹42.79 (17 Aug 2026), low ₹29.27 (12 Mar 2026).
Financials, as filed
Revenue fell 27.8% a year over 2 years, FY24 to FY26. Operating margin widened to 3.6%.
| Year ending | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹194 Cr | ₹118 Cr | ₹101 Cr |
| Operating profit | ₹-9 Cr | ₹1 Cr | ₹4 Cr |
| Operating margin | -4.8% | 1.0% | 3.6% |
| Interest | ₹3 Cr | ₹2 Cr | ₹2 Cr |
| Depreciation | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net profit | ₹-13 Cr | ₹-1 Cr | ₹1 Cr |
| Net margin | -6.5% | -1.2% | 1.1% |
| Cash from operations | ₹-6 Cr | ₹22 Cr | ₹-14 Cr |
| Free cash flow | ₹-6 Cr | ₹21 Cr | ₹-14 Cr |
| ROCE | -12.0% | 2.0% | 6.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
| Reserves | ₹32 Cr | ₹42 Cr | ₹42 Cr | ₹30 Cr | ₹26 Cr | ₹30 Cr |
| Borrowings | ₹22 Cr | ₹27 Cr | ₹34 Cr | ₹40 Cr | ₹24 Cr | ₹36 Cr |
| Other liabilities | ₹10 Cr | ₹3 Cr | ₹9 Cr | ₹4 Cr | ₹4 Cr | ₹7 Cr |
| Total liabilities | ₹68 Cr | ₹76 Cr | ₹89 Cr | ₹78 Cr | ₹57 Cr | ₹76 Cr |
| Fixed assets | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹5 Cr | ₹6 Cr |
| Capital work in progress | ₹0 Cr | ₹0 Cr | ₹2 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr |
| Investments | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other assets | ₹66 Cr | ₹71 Cr | ₹83 Cr | ₹72 Cr | ₹51 Cr | ₹70 Cr |
| Total assets | ₹68 Cr | ₹76 Cr | ₹89 Cr | ₹78 Cr | ₹57 Cr | ₹76 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, the public added +0.37 pp while promoters trimmed −0.34 pp. The shareholder count grew 1% to 3,099.
- Promoters
- 41.8%
- DIIs
- 1.9%
- Public
- 56.3%
Since Jun 2025
- Public +0.37 pp
- Promoters −0.34 pp
- DIIs −0.03 pp
How it drifted, 12 quarters
Over this window the public went from 53.7% to 56.3% — +2.6 pp.
Ownership split by quarter, oldest first. Sep '23: Promoters 44.4%, DIIs 1.9%, Public 53.7%.Dec '23: Promoters 43.8%, DIIs 1.9%, Public 54.3%.Mar '24: Promoters 43.7%, DIIs 1.9%, Public 54.4%.Jun '24: Promoters 43.3%, DIIs 1.9%, Public 54.8%.Sep '24: Promoters 42.6%, DIIs 1.9%, Public 55.4%.Dec '24: Promoters 42.2%, DIIs 1.9%, Public 55.9%.Mar '25: Promoters 42.2%, DIIs 1.9%, Public 55.9%.Jun '25: Promoters 42.2%, DIIs 1.9%, Public 55.9%.Sep '25: Promoters 42.1%, DIIs 1.9%, Public 55.9%.Dec '25: Promoters 41.8%, DIIs 1.9%, Public 56.3%.Mar '26: Promoters 41.8%, DIIs 1.9%, Public 56.3%.Jun '26: Promoters 41.8%, DIIs 1.9%, Public 56.3%.
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Thyagarajan Gurumurthy +0.19 pp 2.69% held
The same filing shows 0 holders trimming and 0 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of Natraj Proteins Ltd. above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Sharad Kumar Jain | 6.38% | unchanged |
| Rajesh Kumar Agrawal | 5.89% | unchanged |
| Sangeetha S . | 5.75% | unchanged |
| Rajeev Kumar Sharma | 5.15% | unchanged |
| Arush Arora | 4.95% | unchanged |
| Kailash Chand Sharma | 4.40% | unchanged |
| Avinash Kumar Sharma | 3.59% | unchanged |
| Sanjay Sharma | 3.22% | unchanged |
| Sumanlatha Sharma | 2.80% | unchanged |
| Thyagarajan Gurumurthy | 2.69% | +0.19 pp |
| Parveen Arora | 2.08% | unchanged |
| Benishanka R Sharma | 1.97% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse Natraj Proteins Ltd.
Guides on how to read this kind of business and the numbers that matter.